(265 days)
Not Found
No
The device description focuses on the physical components and materials of a sheath, dilator, and guidewire, with no mention of software, algorithms, or data processing that would indicate AI/ML. The "Mentions AI, DNN, or ML" section is explicitly marked as "Not Found".
No.
The device is described as an introducer sheath and dilator, indicated for the "introduction of diagnostic and interventional devices" into the vasculature. Its primary role is to facilitate the insertion of other devices, not to provide therapy itself. While it enables therapeutic procedures, it is not inherently therapeutic.
No
The device is an introducer sheath, guidewire, and dilator used to facilitate the introduction of other diagnostic and interventional devices into the vasculature. It does not perform diagnostic functions itself.
No
The device description clearly outlines physical components such as a sheath, dilator, and guidewire, made of materials like ETFE, polyamide, polypropylene, and FEP. It also mentions physical features like radiopaque markers, hubs, side tubes, and suture wings. There is no mention of software as a component or function of the device.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is for the "introduction of diagnostic and interventional devices inserted into the peripheral and coronary vasculature." This describes a device used in vivo (within the body) to facilitate other procedures, not a device used in vitro (outside the body) to examine specimens from the body.
- Device Description: The description details a sheath, dilator, and guidewire designed for insertion into blood vessels. These are all components used directly in a medical procedure on a patient.
- Lack of IVD Characteristics: There is no mention of analyzing biological specimens (blood, urine, tissue, etc.) or providing diagnostic information based on such analysis. The device's function is purely mechanical and procedural.
Therefore, the SUPER SHEATH (PROPOSED) is a medical device used for vascular access, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The device is indicated for use in the introduction of diagnostic and interventional devices inserted into the peripheral and coronary vasculature.
Product codes (comma separated list FDA assigned to the subject device)
DYB, DRE
Device Description
Major components of the SUPER SHEATH (PROPOSED) are a sheath and a dilator. In addition, a guidewire is covered under this premarket notification. The guidewire is placed in the gudiewire case including inserter.
The sheath for the SUPER SHEATH (PROPOSED) is named as the SUPER SHEATH (PROPOSED) Introducer Sheath and is available in 4F- 9F diameters and in lengths ranging from 7 to 25 cm. Some types of sheaths have radiopaque markers. The SUPER SHEATH (PROPOSED) are provided sterile and are intended for one procedure use only.
The one-piece construction of the sheath shaft and hub allows smooth passage of concomitantly interventional medical devices. The sheath shaft and hub are made of Ethylene Tetrafluoro ethylene (ETFE) and polyamide.
The hubs, color-coded by French size, contain a hemostatic valve to minimize blood leakage during a procedure. A side tube equipped with a three-way stopcock is attached to the sheath hub. The side tube extension may be used for fluid and medication administration, as well as blood sampling. Some types of sheaths contain a marker band that is embedded in the shaft approximately 2.0 mm from the distal tip.
The dilator is an open tapered plastic tube with an integral luer hub for guidewire insertion. The dilator is inserted into the introducer sheath. The dilator is longer than the sheath with a rounded tapered distal tip. The dilator facilitates and supports the entry of the sheath into the patient's vasculature. Once the sheath is in place the dilator is removed. There are two different dilator distal tip sizes, 0.038" and 0.035" guidewire compatible. The 4F dilators are only available with a 0.035" guidewire lumen dilator. The 5-9F dilators are available with a 0.035" or 0.038" guidewire lumen. The 4bes are made from Polypropylene (PP). The 9F dilator tubes are made of Fluorinated Ethylene Propylene (FEP). The dilator tubes are attached to the inner hub with a metal bush. The sheath hub and the dilator hub lock using a rotating motion.
The SUPER SHEATH (PROPOSED) has a polypropylene suture wing which is color coded by French size. The suture wing is a small projection near the hub with a hole in it for correct placement of the sheath using sutures.
The uncoated guidewire is made of a stainless steel coil wrapped tightly around an inner mandrel that tapers at the distal tip. The flexible tip is J-shaped available in diameters of 0.035" and 0.038". The guidewire, with inserter, is available in 45 cm and 80 cm lengths. The inserter is used strictly for guiding the guidewire into a cannula or introducer.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Peripheral and coronary vasculature.
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Bench Testing:
- Sheath Shaft Tensile Test
- Sheath Kink Test
- Sheath Hub to Shaft Tensile Test
- Valve Integrity of Sheath
- Sheath Lubricity Test
- Sheath Radiopacity Test
- Cover Tube Durability Test
- Hemostatic Valve Integrity/Sheath Pressure Test
- Sheath/Dilator Corrosion Resistance Test
- Dilator Shaft Tensile Test
- Dilator Hub to Shaft Tensile Test
- Guidewire Tensile Test
- Guidewire Combined Load Test
- Guidewire Torqueability Test
- Guidewire Radiopacity Test
- Guidewire Corrosion Resistance Test
Biocompatibility Testing:
- Cytotoxicity
- Intracutaneous reactivity
- Sensitization
- Acute Systemic Toxicity
- Hemocompatibility
- Pyrogen test
- LAL test
Key results: Bench testing demonstrated that the performance of the main body of the SUPER SHEATH (PROPOSED) was comparable to that of the SUPER SHEATH (K052557). Biocompatibility testing demonstrated that the SUPER SHEATH (PROPOSED) does not raise any biocompatibility concern.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 870.1310 Vessel dilator for percutaneous catheterization.
(a)
Identification. A vessel dilator for percutaneous catheterization is a device which is placed over the guide wire to enlarge the opening in the vessel, and which is then removed before sliding the catheter over the guide wire.(b)
Classification. Class II (performance standards).
0
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
January 15, 2015
Togo Medikit Co., Ltd. Izumi Maruo Senior Consultant 4-1-17 Hongo Bunkyo-ku, 113-0033 JA
Re: K141070 Trade/Device Name: Super Sheath Regulation Number: 21 CFR 870.1340 Regulation Name: Catheter Introducer Regulatory Class: Class II Product Code: DYB, DRE Dated: December 8, 2014 Received: December 12, 2014
Dear Izumi Maruo,
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in
1
the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Melissa A. Torres -S
Bram D. Zuckerman, M.D. For Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K141070
Device Name SUPER SHEATH
Indications for Use (Describe)
The device is indicated for use in the introduction of diagnostic and interventional devices inserted into the peripheral and coronary vasculature.
Type of Use (Select one or both, as applicable)
_ Prescription Use (Part 21 CFR 801 Subpart D)
_ Over-The-Counter Use (21 CFR 801 Subpart C)
PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON A SEPARATE PAGE IF NEEDED.
FOR FDA USE ONLY
Concurrence of Center for Devices and Radiological Health (CDRH) (Signature)
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
TOGO MEDIKIT CO., LTD.
17148-6, Aza Kamekawa, Oaza Hichiya, Hyuga City
Miyazaki Prefecture 883-0062, Japan
TELEPHONE: +81-982-53-8027
FACSIMILE: +81-982-53-8008
510(k) Summary
- a. Owner/Company name, address TOGO MEDIKIT CO., LTD. 17148-6 Aza Kamekawa, Oaza Hichiya Hyuga City, Miyazaki Prefecture, 883-0062, Japan
Daisuke Nagamizu Manager, Regulatory Affairs Section, Quality Assurance Department Phone: 011-81-982-53-8000 011-81-982-53-8008 Fax: Email: qc@togomedikit.co.jp
b. Contact/Application Correspondent
Izumi Maruo Senior Consultant MIC International 4-1-17 Hongo, Bunkyo-ku Tokyo, 113-0033, Japan
Phone: 011-81-3-3818-8577 011-81-3-3818-8573 Fax: Email: maruo@mici.co.jp
c. Date prepared
April 18, 2014
d. Name of device
| Trade Name: | SUPER SHEATH |
|---|---|
| Common Name: | Introducer, Catheter |
| Classification Name: | Catheter Introducer |
| Classification Regulation: | 21 CFR 870.1340 |
| Product Code: | DYB |
| Classification Panel: | Cardiovascular |
4
Image /page/4/Picture/0 description: The image shows a logo with a globe-like structure in the background. A stylized human figure is superimposed on the globe. The figure is white, while the globe is gray. The logo appears to represent a global organization or initiative focused on people.
e. Predicate devices
The SUPER SHEATH is substantially equivalent to the following legally marketed devices:
| 510(k): | K052557 |
|---|---|
| Trade name: | Super Sheath Introducer Sheath and Introducer Sheath Sets, 4F-9F |
| Regulation Number: | 21 CFR 870.1310 |
| Product code: | DRE |
| 510(k): | K121504 |
| Trade name: | Super Sheath Introducer Sheath and Introducer Sheath Sets, 3.3F |
| Regulation Number: | 21 CFR 870.1340 |
| Product code: | DYB |
Since the same name as predicate device is used, the new device under application is hereinafter called "the SUPER SHEATH (PROPOSED)" and the predicate devices are called "the SUPER SHEATH (K052557)" and "the 3.3F SUPER SHEATH (K121504)", respectively, for convenience of discussion in this application.
We are claiming substantial equivalence to product codes DRE and DYB.
f. Description of the device
Major components of the SUPER SHEATH (PROPOSED) are a sheath and a dilator. In addition, a guidewire is covered under this premarket notification. The guidewire is placed in the gudiewire case including inserter.
The sheath for the SUPER SHEATH (PROPOSED) is named as the SUPER SHEATH (PROPOSED) Introducer Sheath and is available in 4F- 9F diameters and in lengths ranging from 7 to 25 cm. Some types of sheaths have radiopaque markers. The SUPER SHEATH (PROPOSED) are provided sterile and are intended for one procedure use only.
The one-piece construction of the sheath shaft and hub allows smooth passage of concomitantly interventional medical devices. The sheath shaft and hub are made of Ethylene Tetrafluoro ethylene (ETFE) and polyamide.
The hubs, color-coded by French size, contain a hemostatic valve to minimize blood leakage during a procedure. A side tube equipped with a three-way stopcock is attached to the sheath hub. The side tube extension may be used for fluid and medication administration, as well as blood sampling. Some types of sheaths contain a marker band that is embedded in the shaft approximately 2.0 mm from the distal tip.
The dilator is an open tapered plastic tube with an integral luer hub for guidewire insertion. The dilator is inserted into the introducer sheath. The dilator is longer than the sheath with a rounded tapered distal tip. The dilator facilitates and supports the entry of the sheath into the patient's vasculature. Once the sheath is in place the dilator is removed. There are two different dilator distal tip sizes, 0.038" and 0.035" guidewire compatible. The 4F dilators are only available with a 0.035" guidewire lumen dilator. The 5-9F dilators are available with a
5
Image /page/5/Picture/0 description: The image shows a logo with a globe-like structure made of intersecting lines, resembling a wireframe. Inside the globe, there is a stylized human figure with its arms outstretched, as if embracing the world. The figure is positioned in the center of the globe, creating a sense of global unity or connection.
0.035" or 0.038" guidewire lumen. The 4bes are made from Polypropylene (PP). The 9F dilator tubes are made of Fluorinated Ethylene Propylene (FEP). The dilator tubes are attached to the inner hub with a metal bush. The sheath hub and the dilator hub lock using a rotating motion.
The SUPER SHEATH (PROPOSED) has a polypropylene suture wing which is color coded by French size. The suture wing is a small projection near the hub with a hole in it for correct placement of the sheath using sutures.
The uncoated guidewire is made of a stainless steel coil wrapped tightly around an inner mandrel that tapers at the distal tip. The flexible tip is J-shaped available in diameters of 0.035" and 0.038". The guidewire, with inserter, is available in 45 cm and 80 cm lengths. The inserter is used strictly for guiding the guidewire into a cannula or introducer.
g. Indications for Use
Indication for Use
The device is indicated for use in the introduction of diagnostic and interventional devices inserted into the peripheral and coronary vasculature.
h. Statement of substantial equivalence
The main body of the SUPER SHEATH (PROPOSED) was essentially modified from the SUPER SHEATH (K052557). Thus, most of the characteristics of the SUPER SHEATH (PROPOSED) are similar to those of the SUPER SHEATH (K052557). Regarding packaging, the packaging materials and configuration are the same as the 3.3F SUPER SHEATH (K121504).
Comparison table of technological characteristics is as follows;
| Feature | SUPER
(PROPOSED) | SHEATH | SUPER
(K052557) | SHEATH | 3.3F SUPER SHEATH
(K121504) |
|---------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------|--------|-------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications for Use | The device is indicated for use in the introduction of diagnostic and interventional devices inserted into the peripheral and coronary vasculature. | | Introducer Sheaths and Introducer Sheath Sets are intended for use in the introduction of diagnostic and interventional devices into the human vasculature. | | The Super Sheath Introducer Sheaths and Super Sheath Introducer Sheath Sets are indicated for use in the introduction of diagnostic and interventional devices inserted into the human vasculature of adult and pediatric patients of all ages. |
| Regulation | 870.1340 | | 870.1310 | | 870.1340 |
| Comparison table of technological characteristics | |||
|---|---|---|---|
| Number | |||
| FDA Product Code | DYB | DRE | DYB |
| Prescription/OTC Use | Prescription | Prescription | Prescription |
| Single-use/Reusab le | Single-use | Single-use | Single-use |
| Sheath | |||
| French Sizes Available | 4F- 9F | 4F- 9F | 3.3F |
| Effective Length | 7 cm - 25 cm | 7 cm - 25 cm | 5 cm - 7 cm |
| Sheath Shaft Inner Diameter (ID) | 1.58 mm - 3.23 mm | 1.58 mm - 3.23 mm | 1.30 mm |
| Sheath Shaft Outer Diameter (OD) | 1.98 mm - 3.69 mm | 1.98 mm - 3.69 mm | 1.70 mm |
| Sheath Shaft Materials | Ethylene tetrafluoro ethylene (Neoflon® ETFE EP-526):90% | ||
| Barium Sulfate: 10% | Ethylene tetrafluoro ethylene (Neoflon® ETFE EP-522):85% | ||
| Barium Sulfate: 15% | Ethylene tetrafluoro ethylene (Neoflon® ETFE EP-522):85% | ||
| Barium Sulfate: 15% | |||
| Cover Tube Material | Ethylene tetrafluoro ethylene (Neoflon® ETFE EP-526) | Ethylene tetrafluoro ethylene (Neoflon® ETFE EP-522) | Not Applicable |
| Radiopaque Marker | Tantalum | Tantalum | Not Applicable |
| Dilator | |||
| Dilator Tube Materials | 4F -8F: | ||
| Polypropylene | |||
| 9F: Fluorinated ethylene propylene | 4F -8F: | ||
| Polypropylene | |||
| 9F: Fluorinated ethylene propylene | Polypropylene | ||
| Dilator Tube Inner Diameter (ID) | 4F-8F 0.92 mm – 1.00 mm (0.035" *) | ||
| 1.02 mm– 1.10 mm (0.038" *) | |||
| 9F 0.95 mm – 1.05 mm (0.035" *) | |||
| 1.05 mm– 1.15 mm (0.038" *) | 4F-8F 0.92 mm – 1.00 mm (0.035" *) | ||
| 1.02 mm– 1.10 mm (0.038" *) | |||
| 9F 0.95 mm – 1.05 mm (0.035" *) | |||
| 1.05 mm– 1.15 mm (0.038" *) | 0.65 mm – 0.75 mm | ||
| Dilator Tube | |||
| Outer Diameter | |||
| (OD) | 1.38 mm – 3.09 mm | 1.38 mm – 3.09 mm | 1.23 mm |
| Dilator Tube | |||
| Effective Length | 13 cm – 31 cm | ||
| (130 mm – 310 mm) | 13 cm – 31 cm | ||
| (130 mm – 310 mm) | 10.5 cm to 12.5 cm | ||
| (105 mm – 125 mm) | |||
| Dilator Distal Tip | 0.035”* | ||
| 0.038” * | 0.035” * | ||
| 0.038” * | 0.018” | ||
| 0.021” | |||
| 0.025” | |||
| Guidewire and Inserter | |||
| Guidewire | |||
| Tip | |||
| Shape | J-tip | J-tip | Straight type |
| Outer Diameter | 0.035”, 0.038” | 0.035”, 0.038” | 0.025” |
| Inserter | Available | Available | Available |
| Sterilization and Shelf-life | |||
| Sterilization | |||
| method | Ethylene oxide | Ethylene oxide | Ethylene oxide |
| Sterile Package | Pouch | Blister package | Pouch |
| Shelf-Life | Two (2) years | Three (3) years | Three (3) years |
6
Image /page/6/Picture/0 description: The image shows a logo with a globe and a stylized figure in the center. The figure appears to be reaching upwards, and the globe is depicted with lines of latitude and longitude. The logo is rendered in a grayscale color scheme, giving it a simple and professional appearance.
OGO MEDIKIT CO., LT 7148-6. Aza Kamekawa. Oaza Hichiya. Hyuga City
Miyazaki Prefecture 883-0062, Japan TELEPHONE : +81-982-53-8027 FACSIMILE : +81-982-53-8008
7
Image /page/7/Picture/0 description: The image shows a logo with a stylized human figure standing in front of a globe. The globe is represented by a grid of lines, suggesting a network or global reach. The human figure is simplified, with arms raised, creating a sense of connection or outreach. The logo appears to be designed to convey a message of global unity, human connection, or international cooperation.
TOGO MEDIKIT CO., LTD.
7148-6, Aza Kamekawa, Oaza Hichiya, Hyuga Ci
Miyazaki Prefecture 883-0062, Japan
TELEPHONE : +81-982-53-8027
Note*: There are two different dilator distal tip sizes, 0.038" and 0.035" guidewire compatible. Note that the 4F dilators are only available with a 0.035"guidewire lumen dilator. The 5-9F dilators are available with a 0.035" or 0.038" guidewire lumen.
SUPER SHEATH (K052557) referenced regulation number 870.1310 and product code DRE. However 3.3F SUPER SHEATH (K121504) for additional sizes utilized regulation number 870.1340 and product code DYB, which are referenced by the current submission. Citation of 870.1340 /DYB is presumably the most current regulatory practice as evidenced by 3.3F SUPER SHEATH (K121504).
Regarding the main body of the SUPER SHEATH (PROPOSED), major components are a sheath and a dilator. In addition, a guidewire is covered under this premarket notification. The guidewire is placed in the Gudiewire case including inserter. The only difference from the SUPER SHEATH (K052557) is the modifications of material change of the sheath shaft.
In order to evaluate any effects of the above changes on safety and effectiveness for the main body, biocompatibility testing and bench testing including shelf-life testing were performed.-Biocompatibility testing demonstrated that the SUPER SHEATH (PROPOSED) does
8
Image /page/8/Picture/0 description: The image shows a logo with a globe-like structure. The globe is made of vertical and horizontal lines, creating a grid-like pattern. In the center of the globe, there is a stylized human figure with its arms raised. The figure appears to be integrated into the globe's structure, suggesting a connection between humanity and the world.
TOGO MEDIKIT CO., LTD.
17148-6, Aza Kamekawa, Oaza Hichiya, Hyuga City
Miyazaki Prefecture 883-0062, Japan
TELEPHONE: +81-982-53-8027
FACSIMILE: +81-982-53-8008
not raise any biocompatibility concern. testing including shelf-life testing demonstrated that the performance of the main body of the SUPER SHEATH (PROPOSED) was comparable to that of the SUPER SHEATH (K052557).
Regarding packaging of the SUPER SHEATH (PROPOSED), packaging integrity test and sterility test demonstrates the packaging works as a sterile barrier for the SUPER SHEATH (PROPOSED) and is substantial equivalent to the packaging of the 3.3F SUPER SHEATH (K121504).
Based on above, we concluded that the modification did not raise any new safety or effectiveness concerns compared to the SUPER SHEATH (K052557) for main body and the 3.3F SUPER SHEATH (K121504) for packaging.
i. Bench Testing
The following bench tests were performed to ensure the safety and effectiveness of the SUPER SHEATH (PROPOSED), verify conformity to the international standards and in-house requirements, and demonstrate substantial equivalence to the SUPER SHEATH (K052557).
- Sheath Shaft Tensile Test
- Sheath Kink Test
- Sheath Hub to Shaft Tensile Test
- Valve Integrity of Sheath
- Sheath Lubricity Test
- Sheath Radiopacity Test
- Cover Tube Durability Test
- Hemostatic Valve Integrity/Sheath Pressure Test
- Sheath/Dilator Corrosion Resistance Test
- Dilator Shaft Tensile Test
- . . . . . . . . . . . . . Dilator Hub to Shaft Tensile Test
- Guidewire Tensile Test
- Guidewire Combined Load Test
- Guidewire Torqueability Test
- Guidewire Radiopacity Test
- Guidewire Corrosion Resistance Test
Biocompatibility Testing i.
We performed following biocompatibility tests because of material change of the sheath shaft;
- Cytotoxicity
- Intracutaneous reactivity
- Sensitization
- .... Acute Systemic Toxicity
- Hemocompatibility
- Pyrogen test
- LAL test
SUPER SHEATH APRIL 18, 2014
9
Image /page/9/Picture/0 description: The image shows a logo with a globe and a stylized human figure inside it. The globe is represented by a grid of lines, and the human figure is white. The figure is standing upright with its arms outstretched, forming a T-shape. The logo is simple and conveys a sense of global reach and human connection. The logo is in grayscale.
TOGO MEDIKIT CO., LTD.
17148-6, Aza Kamekawa, Oaza Hichiya, Hyuga City
Miyazaki Prefecture 883-0062, Japan
TELEPHONE: +81-982-53-8027
FACSIMILE: +81-982-53-8008
In the biocompatibility testing reports, no biocompatibility concern was raised.
k. Conclusion
Based on the above discussion and enclosed sections regarding substantial equivalence to predicate devices, TOGO MEDIKIT concludes that the SUPER SHEATH (PROPOSED) is substantially equivalent to the SUPER SHEATH (K052557) and the 3.3F SUPER SHEATH (K121504) , and the SUPER SHEATH (PROPOSED) does not raise any new questions regarding safety or effectiveness.